Stephen Griffin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen Griffin
Stephen Griffin is recorded as CFO at Anika Therapeutics, Inc. (ANIK). Anika Therapeutics, Inc. reported in an 8-K filed May 8, 2024 that Stephen Griffin was appointed Executive Vice President, Chief Financial Officer and Treasurer, effective June 3, 2024.
“On May 8, 2024, Anika Therapeutics, Inc. (the “Company”) announced that Stephen Griffin would be joining the Company as its Executive Vice President, Chief Financial Officer and Treasurer, effective June 3, 2024 (the “Effective Date”), replacing Michael Levitz, who tendered his resignation on May 2, 2024”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Anika Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Cheryl Blanchard CEO, Board Member
- Stephen (Steve) Griffin CEO, Board Member
- Stephen D. Griffin CEO, CFO, Board Member
- Steve Griffin CEO, Board Member
- Cheryl R. Blanchard Chairman, Board Member
- Jeffery S. Thompson Chairman
- John B. Henneman, III Chairman, Board Member
- Michael Levitz CFO
- Anne Nunes COO
- David B. Colleran General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.